Loading…
Medicare DMEPOS Competitive Bidding Improvement Act of 2015
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
76pct
64d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Medicar e DMEPOS Competitive Bidding Improvement Act of 2015 Amends title XVIII (Medicare) of the Social Security Act with respect to the Medicare durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) competitive acquisition program. Prohibits an entity from submitting a bid for a competitive acquisition area, during calendar 2017-2019, unless it has obtained a bid surety bond of between $50,000 and $100,000 for each such area. Requires the forfeit of any bid bond submitted for a competitive acquisition area if the bidding entity does not accept a contract offered for any product category when its composite bid was at or below the median composite bid rate for all bidding entities included in the calculation of the single payment amounts for the product category and the area. Requires the Secretary of Health and Human Services to collect on the forfeited bond. Requires return of a bid bond within a specified 90-day period to a bidding entity that does not meet such bid forfeiture conditions. Prohibits the Secretary from awarding a contract to any entity that does not meet state licensure requirements. Directs the Government Accountability Office to study the effect of this bid surety bond requirement on the participation of small suppliers in the Medicare DMEPOS competitive acquisition program.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Received in the Senate and Read twice and referred to the Committee on Finance.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H1646)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H1646)
DEBATE - The House proceeded with forty minutes of debate on H.R. 284.
Considered under suspension of the rules. (consideration: CR H1646-1647)
Mr. Ryan (WI) moved to suspend the rules and pass the bill, as amended.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 114-38, Part I.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2016 · fourth_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive. - Issues related to Expanded Access. - S. 2736/ HR 5210, "Patient Access to Durable Medical Equipment Act of 2016", regarding all provisions. - Issues related to competitive bidding for DME products. - S. 2484, "Connect for Health Act", Provisions related to expanded use of RPM for certain patients with chronic conditions.
Client expense: $1,460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2016 · fourth_quarter · Medicare/Medicaid
HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; DMEPOS Prior Authorization rules; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015; H.R. 5210 and S. 2736, the Patient Access to Durable Medical Equipment Act of 2016, the Beneficiary Respiratory Equipment Access and Transparency to Home Ventilator Care (BREATH) Act of 2016; H.R.6 and other versions of the 21st Century Cures Act.
Client expense: Not reported · Firm income: $37,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
PL 111-148: Patient Protection and Affordable Care Act (ACA) - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency PL 111-152: Healthcare Education and Reconciliation Act: Imaging cuts, device tax transparency and remote monitoring S.2343 - The Telehealth Innovation and Improvement Act PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services CMS CPAP bundling proposal HR.2396 - The Software Act HR.2437 - To develop and implement a prior authorization process for certain DMEPOS. Fostering Independence Through Technology Act (potential reintroduction) - specifically the telehealth provisions H.R.284/S.128 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2015 Site-neutrality in payments HR 2 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria HR.2066 - Telehealth Enhancement Act of 2015 The Health Care Innovation and Marketplace Technologies Act (potential reintroduction of HR.2363 from 113th Congress) - Telemedicine provisions HR.2948 - The Medicare Telehealth Parity Act (potential reintroduction) HR.2156 - The Medicare Audit Improvement and Reform Act HR.4185 - The Protecting Access Through Competitive Pricing Transition Act of 2015 S.2312 - The DME Access and Stabilization Act S.2736 - Patient Access to Durable Medical Equipment Act of 2016 H.R.5710 - Patient Access to Durable Medical Equipment Act of 2016 S.3195 - The BREATH Act of 2016 HR.6012 - The BREATH Act of 2016 Chronic care Non-invasive ventilators
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
2016 · fourth_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6/H.R. 34 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions; H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions; S. 2736/H.R. 5210 - Patient Access to Durable Medical Equipment Act of 2016, all provisions.
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2016 · fourth_quarter · Health Issues
IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626 / HR 4756); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); budget reform (HR 3660)
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2016 · third_quarter · Health Issues
IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626 / HR 4756); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); budget reform (HR 3660)
Client expense: $140,000 · Firm income: Not reported
2016 · third_quarter · Medicare/Medicaid
HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015; H.R. 5210 and S. 2736, the Patient Access to Durable Medical Equipment Act of 2016, the Beneficiary Respiratory Equipment Access and Transparency to Home Ventilator Care (BREATH) Act of 2016
Client expense: Not reported · Firm income: $37,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive. - Issues related to Expanded Access. - S. 2736/ HR 5210, "Patient Access to Durable Medical Equipment Act of 2016", regarding all provisions. - Issues related to competitive bidding for DME products. - S. 2484, "Connect for Health Act", Provisions related to expanded use of RPM for certain patients with chronic conditions.
Client expense: $890,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2016 · third_quarter · Medicare/Medicaid
PL 111-148: Patient Protection and Affordable Care Act (ACA) - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency PL 111-152: Healthcare Education and Reconciliation Act: Imaging cuts, device tax transparency and remote monitoring S.2343 - The Telehealth Innovation and Improvement Act PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services CMS CPAP bundling proposal HR.2396 - The Software Act HR.2437 - To develop and implement a prior authorization process for certain DMEPOS. Fostering Independence Through Technology Act (potential reintroduction) - specifically the telehealth provisions H.R.284/S.128 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2015 Site-neutrality in payments HR 2 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria HR.2066 - Telehealth Enhancement Act of 2015 The Health Care Innovation and Marketplace Technologies Act (potential reintroduction of HR.2363 from 113th Congress) - Telemedicine provisions HR.2948 - The Medicare Telehealth Parity Act (potential reintroduction) HR.2156 - The Medicare Audit Improvement and Reform Act HR.4185 - The Protecting Access Through Competitive Pricing Transition Act of 2015 S.2312 - The DME Access and Stabilization Act S.2736 - Patient Access to Durable Medical Equipment Act of 2016 H.R.5710 - Patient Access to Durable Medical Equipment Act of 2016 S.3195 - The BREATH Act of 2016 HR.6012 - The BREATH Act of 2016 Chronic care Non-invasive ventilators
2016 · third_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions; H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions; S. 2736/H.R. 5210 - Patient Access to Durable Medical Equipment Act of 2016, all provisions.
Client expense: $150,000 · Firm income: Not reported
2016 · second_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive. - Issues related to Expanded Access. - S. 2736, "Patient Access to Durable Medical Equipment Act of 2016", regarding all provisions.
Client expense: $2,040,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2016 · second_quarter · Medicare/Medicaid
HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015; H.R. 5210 and S. 2736, the Patient Access to Durable Medical Equipment Act of 2016
Client expense: Not reported · Firm income: $37,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Health Issues
IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626 / HR 4756); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); budget reform (HR 3660)
Client expense: $140,000 · Firm income: Not reported
2016 · second_quarter · Medicare/Medicaid
PL 111-148: Patient Protection and Affordable Care Act (ACA) - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency PL 111-152: Healthcare Education and Reconciliation Act: Imaging cuts, device tax transparency and remote monitoring S.2343 - The Telehealth Innovation and Improvement Act PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services CMS CPAP bundling proposal HR.2396 - The Software Act HR.2437 - To develop and implement a prior authorization process for certain DMEPOS. Fostering Independence Through Technology Act (potential reintroduction) - specifically the telehealth provisions H.R.284/S.128 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2015 Site-neutrality in payments HR 2 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria HR.2066 - Telehealth Enhancement Act of 2015 The Health Care Innovation and Marketplace Technologies Act (potential reintroduction of HR.2363 from 113th Congress) - Telemedicine provisions HR.2948 - The Medicare Telehealth Parity Act (potential reintroduction) HR.2156 - The Medicare Audit Improvement and Reform Act HR.4185 - The Protecting Access Through Competitive Pricing Transition Act of 2015 S.2312 - The DME Access and Stabilization Act S.2736 - Patient Access to Durable Medical Equipment Act of 2016 H.R.5710 - Patient Access to Durable Medical Equipment Act of 2016 Chronic care Non-invasive ventilators
Client expense: $600,000 · Firm income: Not reported
2016 · second_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions; H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions; S. 2736/H.R. 5210 - Patient Access to Durable Medical Equipment Act of 2016, all provisions.
Client expense: $140,000 · Firm income: Not reported
2016 · first_quarter · Medicare/Medicaid
HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015; S. 2736, the Patient Access to Durable Medical Equipment Act of 2016
Client expense: Not reported · Firm income: $37,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2016 · first_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive. - Issues related to Expanded Access. - S. 2736, "Patient Access to Durable Medical Equipment Act of 2016", regarding all provisions.
Client expense: $1,140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2016 · first_quarter · Medicare/Medicaid
PL 111-148: Patient Protection and Affordable Care Act (ACA) - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency PL 111-152: Healthcare Education and Reconciliation Act: Imaging cuts, device tax transparency and remote monitoring S.2343 - The Telehealth Innovation and Improvement Act PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services CMS CPAP bundling proposal HR.2396 - The Software Act HR.2437 - To develop and implement a prior authorization process for certain DMEPOS. Fostering Independence Through Technology Act (potential reintroduction) - specifically the telehealth provisions H.R.284/S.128 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2015 Site-neutrality in payments HR 2 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria HR.2066 - Telehealth Enhancement Act of 2015 The Health Care Innovation and Marketplace Technologies Act (potential reintroduction of HR.2363 from 113th Congress) - Telemedicine provisions HR.2948 - The Medicare Telehealth Parity Act (potential reintroduction) HR.2156 - The Medicare Audit Improvement and Reform Act HR.4185 - The Protecting Access Through Competitive Pricing Transition Act of 2015 S.2312 - The DME Access and Stabilization Act S.2736 - Patient Access to Durable Medical Equipment Act of 2016 Chronic care Non-invasive ventilators
Client expense: $380,000 · Firm income: Not reported
2016 · first_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions. H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions; S. 2736 - Patient Access to Durable Medical Equipment Act of 2016, all provisions.
Client expense: $120,000 · Firm income: Not reported
2016 · first_quarter · Health Issues
IPAB Repeal (HR 1190 / S 141); Medical Liability Reform (HR 4771); Medicare physician payment / SGR (HR 2); Medicare Therapeutic Shoes program for persons with diabetes (HR 1221 / S 626); Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Medicaid program integrity (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425; S 2511); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526, S 2368); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)
Client expense: $140,000 · Firm income: Not reported
2015 · fourth_quarter · Medicare/Medicaid
Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy. CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies. Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity. Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues. Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals. Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers. Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services. H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - preventing cuts to Medicare home oxygen services. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - preventing cuts to Medicare home oxygen services. H.R.284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 4185, Protecting Access through Competitive-pricing Transition (PACT) Act, all provisions. S. 2312, the DME Access and Stabilization Act, all provisions. S. 2368, Audit & Appeals Fairness, Integrity, and Reforms in Medicare Act of 2015, all provisions. Public Law 114-113, Consolidated Appropriations Act, 2016, provisions relating to Medicare and Medicaid payment for durable medical equipment. Public Law 114-74, Bipartisan Budget Act of 2015, provisions relating to Medicare and and Medicaid payment for durable medical equipment.
Client expense: Not reported · Firm income: $75,000
2015 · fourth_quarter · Medicare/Medicaid
HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; GAO and OIG reports related to DMEPOS; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation; DMEPOS prior authorization proposed and final rule; S. 2312,DME Access and Stabilization Act of 2015; H.R. 4185, Protecting Access through Competitive�pricing Transition Act of 2015.
Client expense: Not reported · Firm income: $37,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2015 · fourth_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive.
Client expense: $1,210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2015 · fourth_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive.
Client expense: $1,260,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2015 · fourth_quarter · Health Issues
Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) Medical Device related issues Medicare Audit Improvement Act, Medical Device issues Administrative Relief and Accurate Medicare Payments, Medical device issues H.R.1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, Medical device issues Public Law 114-10, Medicare Access and CHIP Reauthorization Act of 2015, Medical device issues H.R.284/S.148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015, Medical device issues H.R.6, 21st Century Cures Act, Medical device issues H.R.4185, Protecting Access through Competitive-pricing Transition (PACT) Act of 2015, Medical device issues S.2312, DME Access and Stabilization Act of 2015, Medical device issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Medicare/Medicaid
PL 111-148: Patient Protection and Affordable Care Act (ACA) - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency PL 111-152: Healthcare Education and Reconciliation Act: Imaging cuts, device tax transparency and remote monitoring S.2343 - The Telehealth Innovation and Improvement Act PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services CMS CPAP bundling proposal HR.2396 - The Software Act HR.2437 - To develop and implement a prior authorization process for certain DMEPOS. Fostering Independence Through Technology Act (potential reintroduction) - specifically the telehealth provisions H.R.284/S.128 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2015 Site-neutrality in payments (no bill number yet) HR 2 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria HR.2066 - Telehealth Enhancement Act of 2015 The Health Care Innovation and Marketplace Technologies Act (potential reintroduction of HR.2363 from 113th Congress) - Telemedicine provisions HR.2948 - The Medicare Telehealth Parity Act (potential reintroduction) HR.2156 - The Medicare Audit Improvement and Reform Act HR.4185 - The Protecting Access Through Competitive Pricing Transition Act of 2015 S.2312 - The DME Access and Stabilization Act Chronic care Non-invasive ventilators
Client expense: $330,000 · Firm income: Not reported
2015 · fourth_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act, all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions. H.R. 2029 - Omnibus Appropriations Bill, DME provisions; S. 2425 - Patient Access and Medicare Protection Act, all provisions; H.R. 4185/S. 2312 - DME Rural Relief, all provisions; H.R. 3229/S. 2196 - Complex Rehab Accessories Relief, all provisions.
Client expense: $130,000 · Firm income: Not reported
2015 · fourth_quarter · Health Issues
IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270; S 2425); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018; HR 2029); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)
Client expense: $140,000 · Firm income: Not reported
2015 · third_quarter · Medicare/Medicaid
Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy. CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies. Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity. Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues. Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals. Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers. Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services. H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - preventing cuts to Medicare home oxygen services. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - preventing cuts to Medicare home oxygen services. H.R.284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015.
Client expense: Not reported · Firm income: $75,000
2015 · third_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive.
Client expense: $780,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2015 · third_quarter · Medicare/Medicaid
HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; GAO and OIG reports related to DMEPOS; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule implementation.
Client expense: Not reported · Firm income: $37,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2015 · third_quarter · Health Issues
Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) Medical Device related issues Medicare Audit Improvement Act, Medical Device issues Administrative Relief and Accurate Medicare Payments, Medical device issues H.R.1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, Medical device issues Public Law 114-10, Medicare Access and CHIP Reauthorization Act of 2015, Medical device issues H.R.284/S.148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015, Medical device issues H.R.6, 21st Century Cures Act, Medical device issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Medicare/Medicaid
PL 111-148: Patient Protection and Affordable Care Act (ACA) - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency PL 111-152: Healthcare Education and Reconciliation Act: Imaging cuts, device tax transparency and remote monitoring Medicare OSA Sleep Testing and potential reintroduction PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services CMS CPAP bundling proposal HR.2396 - The Software Act HR.2437 - To develop and implement a prior authorization process for certain DMEPOS. Fostering Independence Through Technology Act (potential reintroduction) - specifically the telehealth provisions H.R.284/S.128 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2015 Site-neutrality in payments (no bill number yet) HR 2 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria HR.2066 - Telehealth Enhancement Act of 2015 The Health Care Innovation and Marketplace Technologies Act (potential reintroduction of HR.2363 from 113th Congress) - Telemedicine provisions HR.2948 - The Medicare Telehealth Parity Act (potential reintroduction) HR.2156 - The Medicare DMEPOS Audit Improvement and Reform Act Chronic care
Client expense: $410,000 · Firm income: Not reported
2015 · third_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act; all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Re-authorization Act of 2015, competitive bidding provisions.
Client expense: $110,000 · Firm income: Not reported
2015 · third_quarter · Health Issues
IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661)
Client expense: $140,000 · Firm income: Not reported
2015 · second_quarter · Medicare/Medicaid
Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy. CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies. Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity. Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues. Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals. Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers. Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services. H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - preventing cuts to Medicare home oxygen services. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - preventing cuts to Medicare home oxygen services. H.R.284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015.
Client expense: Not reported · Firm income: $75,000
2015 · second_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions.
Client expense: $2,420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2015 · second_quarter · Medicare/Medicaid
HR 2 Medicare Access and CHIP Reauthorization Act of 2015 (incorporating HR 284 and S. 148, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015), Pub. L. No. 114-10; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; GAO and OIG reports related to DMEPOS; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule.
Client expense: Not reported · Firm income: $37,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2015 · second_quarter · Health Issues
Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) Medical Device related issues Medicare Audit Improvement Act, Medical Device issues Administrative Relief and Accurate Medicare Payments, Medical device issues H.R.1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, Medical device issues Public Law 114-10, Medicare Access and CHIP Reauthorization Act of 2015, Medical device issues H.R.284/S.148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015, Medical device issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Medicare/Medicaid
PL 111-148: Patient Protection and Affordable Care Act (ACA) - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency PL 111-152: Healthcare Education and Reconciliation Act: Imaging cuts, device tax transparency and remote monitoring Medicare OSA Sleep Testing and potential reintroduction PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services CMS CPAP bundling proposal HR.2396 - The Software Act HR.2437 - To develop and implement a prior authorization process for certain DMEPOS. Fostering Independence Through Technology Act (potential reintroduction) - specifically the telehealth provisions H.R.284/S.128 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2015 Site-neutrality in payments (no bill number yet) HR 2 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria HR.2066 - Telehealth Enhancement Act of 2015 The Health Care Innovation and Marketplace Technologies Act (potential reintroduction) - Telemedicine provisions The Medicare Telehealth Parity Act (potential reintroduction) HR.2156 - The Medicare DMEPOS Audit Improvement and Reform Act Chronic care
Client expense: $500,000 · Firm income: Not reported
2015 · second_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 1516/S. 1013 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, all provisions; H.R. 284/S. 148 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, all provisions; Medicare Audit Improvement and Reform (AIR) Act; all provisions; Medicare DMEPOS Market Pricing Program Act, all provisions; Reimbursement cuts in non-competitive bidding areas, all provisions; H.R. 6 - 21st Century Cures Act, competitive bidding issues; Complex rehab technology accessories relating to competitive bidding; H.R. 2437 - Creating prior authorization process for DME items, all provisions; Expanding and making permanent the Medicare power mobility device demonstration program, all provisions; Audit and Appeal Fairness, Integrity, and Reforms in the Medicare Act of 2015, all provisions; H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015, competitive bidding provisions.
Client expense: $110,000 · Firm income: Not reported
2015 · second_quarter · Health Issues
IPAB Repeal (HR 1190 / S 141); Medical Liability Reform; Medicare physician payment / SGR (HR 2; HR 1470; S 810); Medicare Therapeutic Shoes program for persons with diabetes; Medicare waste, fraud & abuse; Medicaid waste, fraud and abuse; Budget Sequestration; health insurance anti-trust reform (HR 99, HR 105, HR 494); Veterans Admin. provider recruitment, retention and reimbursement; Medicaid access to podiatry (HR 1221 / S 626); Physician Payments Sunshine Act; Electronic Health Records reform (HR 270); health care provider marketing and advertising (HR 1741); Affordable Care Act implementation as it pertains to physicians and providers; MAC / RAC / Medicare audit reform (HR 1526); Medicare private contracting (HR 1650); public disclosure of Medicare claims data; Medicare self-referral issues; RUC reform (HR 2614); (HR 284 / S 148) DMEPOS Competitive Bidding; Patient Access to Disposable Medical Technology Act (HR 1018); (HR 1192 / S 586) Diabetes Clinical Care Commission Act; 21st Century Cures Act (HR 6); orthotics / prosthetics accreditation & licensure (S 829 / HR 1530); Medicare diabetes prevention (HR 2102 / S 1131); definition of full-time employees; ICD-10 implementation; Affordable Care Act repeal; liberalizing Medical Loss Ratio requirements (HR 815 / S 1661); student loan assistance (HR 1707)
Client expense: $140,000 · Firm income: Not reported
2015 · second_quarter · Medicare/Medicaid
H.R. 1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015; H.R. 6, 21st Century Cures Act
Client expense: $138,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · first_quarter · Medicare/Medicaid
Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy. CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies. Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity. Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues. Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals. Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers. Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services. H.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - preventing cuts to Medicare home oxygen services. Public Law 114-10, the Medicare Access and CHIP Reauthorization Act - preventing cuts to Medicare home oxygen services. H.R.284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015.
Client expense: Not reported · Firm income: $75,000
2015 · first_quarter · Health Issues
Public Law 111-148/H.R. 3590, Patient Protection and Affordable Care Act, all provisions and related regulations including: Cadillac Tax-4980I, Transitional Reinsurance Program 1341, ACA Reporting (IRC 6055 and 6056), ACA shared Responsibility for Employers Provisions, wellness issues (42 USC 12112; 29 CFR 1635.3). H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015, all provisions. H.R.1470 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions. H.R.284 - Medicare DMEPOS Competitive Bidding Improvement Act of 2015, provisions. H.R.1021 - Protecting the Integrity of Medicare Act of 2015, all provisions. H.R.160 - Protect Medical Innovation Act of 2015, all provisions. H.R.248 - American Job Protection Act, healthcare provisions, all provisions. H.R.30- Save American Workers Act of 2015, all provisions. H.R.596 - To repeal the ACA, all provisions. H.R.1189 - Preserving Employee Wellness Programs Act, all provisions. H.R.879 - Ax the Tax on Middle Class Americans' Health Plans Act, all provisions. S.30 - Forty Hours Is Full Time Act of 2015, healthcare provisions. S.305 - American Job Protection Act, all provisions, all provisions. S.620 - Preserving Employee Wellness Programs Act, all provisions GINA (in conjunction with employer-based wellness programs). ADA (in conjunction with employer-based wellness programs).
Client expense: $120,000 · Firm income: Not reported
2015 · first_quarter · Medicare/Medicaid
PL 111-148: Patient Protection and Affordable Care Act (ACA) - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency PL 111-152: Healthcare Education and Reconciliation Act: Imaging cuts, device tax transparency and remote monitoring Medicare OSA Sleep Testing and potential reintroduction PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services Fostering Independence Through Technology Act (potential reintroduction) - specifically the telehealth provisions H.R.284/S.128 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2015 Site-neutrality in payments (no bill number yet) HR 2 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria Telehealth Enhancement Act (potential reintroduction) The Health Care Innovation and Marketplace Technologies Act (potential reintroduction) - Telemedicine provisions The Medicare Telehealth Parity Act (potential reintroduction) The Medicare DMEPOS Competitive Bidding Improvement Act (potential reintroduction) The Medicare DMEPOS Audit Improvement and Reform Act (potential reintroduction) Chronic care
Client expense: $470,000 · Firm income: Not reported
2015 · first_quarter · Medicare/Medicaid
HR 2 Medicare Access and CHIP Reauthorization Act of 2015; HR 284 Medicare DMEPOS Competitive Bidding Improvement Act of 2015; S 148 Medicare DMEPOS Competitive Bidding Improvement Act of 2015; Medicare audit issues related to reimbursement and implementation of the DMEPOS competitive bidding program; Implementing P.L 113-93 the Protecting Access to Medicare Act of 2014; HR 1021 Protecting the Integrity of Medicare Act of 2015; GAO and OIG reports related to DMEPOS; DMEPOS Prior Authorization proposed rule; DMEPOS Medicare payment proposed rule and final rule.
Client expense: Not reported · Firm income: $37,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Medicare/Medicaid
- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions.
Client expense: $1,820,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2015 · first_quarter · Medicare/Medicaid
H.R. 1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015; H.R. 284 and S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015
Client expense: $201,631 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · first_quarter · Health Issues
Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) Medical Device related issues Medicare Audit Improvement Act, Medical Device issues Administrative Relief and Accurate Medicare Payments, Medical device issues H.R.1516, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015, Medical device issues H.R.2, Medicare Access and CHIP Reauthorization Act of 2015, Medical device issues Public Law 113-93, Protecting Access to Medicare Act of 2014, Medical device issues H.R.284/S.148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015, Medical device issues
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Sponsor introductory remarks on measure. (CR E133)
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Referred to |
| January 12, 2015 |
| Energy and Commerce Committee | House | Referred to | January 12, 2015 |
| Republican |
| MO |
| Bob Gibbs | Republican | OH |
| Bobby L. Rush | Democratic | IL |
| Bradley Byrne | Republican | AL |
| Candice S. Miller | Republican | MI |
| Charles B. Rangel | Democratic | NY |
| Chellie Pingree | Democratic | ME |
| Collin C. Peterson | Democratic | MN |
| Daniel Webster | Republican | FL |
| David Loebsack | Democratic | IA |
| David P. Joyce | Republican | OH |
| David P. Roe | Republican | TN |
| David Scott | Democratic | GA |
| David Young | Republican | IA |
| Diane Black | Republican | TN |
| Earl Blumenauer | Democratic | OR |
| Ed Perlmutter | Democratic | CO |
| Ed Whitfield | Republican | KY |
| Eric A. "Rick" Crawford | Republican | AR |
| Erik Paulsen | Republican | MN |
| Glenn Thompson | Republican | PA |
| Gregg Harper | Republican | MS |
| Gus M. Bilirakis | Republican | FL |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| J. Randy Forbes | Republican | VA |
| Jackie Walorski | Republican | IN |
| James R. Langevin | Democratic | RI |
| Jim Jordan | Republican | OH |
| John B. Larson | Democratic | CT |
| John Lewis | Democratic | GA |
| Keith J. Rothfus | Republican | PA |
| Lou Barletta | Republican | PA |
| Louise McIntosh Slaughter | Democratic | NY |
| Mark E. Amodei | Republican | NV |
| Marsha Blackburn | Republican | TN |
| Michael T. McCaul | Republican | TX |
| Mike Kelly | Republican | PA |
| Mo Brooks | Republican | AL |
| Niki Tsongas | Democratic | MA |
| Peter J. Visclosky | Democratic | IN |
| Peter T. King | Republican | NY |
| Randy Neugebauer | Republican | TX |
| Renee L. Ellmers | Republican | NC |
| Richard L. Hanna | Republican | NY |
| Robert B. Aderholt | Republican | AL |
| Robert E. Latta | Republican | OH |
| Robert Pittenger | Republican | NC |
| Rod Blum | Republican | IA |
| Ron Kind | Democratic | WI |
| Scott R. Tipton | Republican | CO |
| Steve King | Republican | IA |
| Steve Stivers | Republican | OH |
| Tammy Duckworth | Democratic | IL |
| Thomas Massie | Republican | KY |
| Tim Ryan | Democratic | OH |
| Todd Rokita | Republican | IN |
| Todd Young | Republican | IN |
| Tom Emmer | Republican | MN |
| Tom Price | Republican | GA |
| Tom Reed | Republican | NY |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Government targets: Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Government targets: Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Government targets: Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Administration for Children & Families (ACF), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), SENATE
Government targets: Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), SENATE, Social Security Administration (SSA), Treasury, Dept of
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE